在急诊科启动姑息治疗:一项整群随机临床试验
该整群随机阶梯楔形临床试验纳入美国29个急诊科中66岁及以上、Gagne合并症评分大于6的98 922例次初始急诊就诊,评估在急诊科启动多组分姑息治疗干预对住院、后续医疗使用和生存的影响。结果显示干预前后住院率无显著差异(校正OR 1.03,95%CI 0.93-1.14),次要结局亦无差异。
要点
- 在急诊科启动多组分姑息治疗干预未降低老年重症患者的住院率。
- 干预前后住院率分别为64.4%和61.3%,校正OR 1.03(95%CI 0.93-1.14)。
- ICU入住、急诊再访、临终关怀使用、家庭健康使用、再住院和死亡等次要结局均无差异。
核心结论
- 在急诊科启动多组分姑息治疗干预对患有严重、限制生命疾病的老年人的住院、后续医疗使用或短期死亡率没有影响。
研究设计与样本
- 整群随机阶梯楔形临床试验,纳入美国29个急诊科中年龄66岁及以上、有12个月既往Medicare参保记录且Gagne合并症评分大于6(代表短期死亡风险大于30%)的患者,排除养老院患者。
- 研究期间为2018年5月1日至2022年12月31日,共纳入98 922例次初始急诊就诊,中位年龄77岁(IQR 71-84岁),50%为女性,13%为黑人,78%为白人,中位Gagne合并症评分为8(IQR 7-10)。
主要发现
- 住院率在干预前阶段为64.4%,干预后阶段为61.3%(绝对差异-3.1%[95%CI -3.7%至-2.5%];校正OR 1.03[95%CI 0.93至1.14])。
- 重症监护室入住率在干预前阶段为7.8%,干预后阶段为6.7%(校正OR 0.98[95%CI 0.83至1.15])。
- 至少1次急诊再访率在干预前阶段为34.2%,干预后阶段为32.2%(校正OR 1.00[95%CI 0.91至1.09])。
- 临终关怀使用率在干预前阶段为17.7%,干预后阶段为17.2%(校正OR 1.04[95%CI 0.93至1.16]);家庭健康使用率在干预前阶段为42.0%,干预后阶段为38.1%(校正OR 1.01[95%CI 0.92至1.10])。
- 至少1次再住院率在干预前阶段为41.0%,干预后阶段为36.6%(校正OR 1.01[95%CI 0.92至1.10]);死亡率在干预前阶段为28.1%,干预后阶段为28.7%(校正OR 1.07[95%CI 0.98至1.18])。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The emergency department (ED) offers an opportunity to initiate palliative care for older adults with serious, life-limiting illness. OBJECTIVE: To assess the effect of a multicomponent intervention to initiate palliative care in the ED on hospital admission, subsequent health care use, and survival in older adults with serious, life-limiting illness. DESIGN, SETTING, AND PARTICIPANTS: Cluster randomized, stepped-wedge, clinical trial including patients aged 66 years or older who visited 1 of 29 EDs across the US between May 1, 2018, and December 31, 2022, had 12 months of prior Medicare enrollment, and a Gagne comorbidity score greater than 6, representing a risk of short-term mortality greater than 30%. Nursing home patients were excluded. INTERVENTION: A multicomponent intervention (the Primary Palliative Care for Emergency Medicine intervention) included (1) evidence-based multidisciplinary education; (2) simulation-based workshops on serious illness communication; (3) clinical decision support; and (4) audit and feedback for ED clinical staff. MAIN OUTCOME AND MEASURES: The primary outcome was hospital admission. The secondary outcomes included subsequent health care use and survival at 6 months. RESULTS: There were 98 922 initial ED visits during the study period (median age, 77 years [IQR, 71-84 years]; 50% were female; 13% were Black and 78% were White; and the median Gagne comorbidity score was 8 [IQR, 7-10]). The rate of hospital admission was 64.4% during the preintervention period vs 61.3% during the postintervention period (absolute difference, -3.1% [95% CI, -3.7% to -2.5%]; adjusted odds ratio [OR], 1.03 [95% CI, 0.93 to 1.14]). There was no difference in the secondary outcomes before vs after the intervention. The rate of admission to an intensive care unit was 7.8% during the preintervention period vs 6.7% during the postintervention period (adjusted OR, 0.98 [95% CI, 0.83 to 1.15]). The rate of at least 1 revisit to the ED was 34.2% during the preintervention period vs 32.2% during the postintervention period (adjusted OR, 1.00 [95% CI, 0.91 to 1.09]). The rate of hospice use was 17.7% during the preintervention period vs 17.2% during the postintervention period (adjusted OR, 1.04 [95% CI, 0.93 to 1.16]). The rate of home health use was 42.0% during the preintervention period vs 38.1% during the postintervention period (adjusted OR, 1.01 [95% CI, 0.92 to 1.10]). The rate of at least 1 hospital readmission was 41.0% during the preintervention period vs 36.6% during the postintervention period (adjusted OR, 1.01 [95% CI, 0.92 to 1.10]). The rate of death was 28.1% during the preintervention period vs 28.7% during the postintervention period (adjusted OR, 1.07 [95% CI, 0.98 to 1.18]). CONCLUSIONS AND RELEVANCE: This multicomponent intervention to initiate palliative care in the ED did not have an effect on hospital admission, subsequent health care use, or short-term mortality in older adults with serious, life-limiting illness. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03424109.
引用
- Grudzen CR, Siman N, Cuthel AM, et al. Palliative Care Initiated in the Emergency Department: A Cluster Randomized Clinical Trial. JAMA. 2025. PMID: 39813042. doi:10.1001/jama.2024.23696
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。